Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
48 hedge funds and large institutions have $577M invested in Myovant Sciences Ltd. in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 9 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
55% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 11
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
7% less capital invested
Capital invested by funds: $621M → $577M (-$44.3M)
8% less funds holding
Funds holding: 52 → 48 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$14.6M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$9.73M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.44M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$3.38M |
| 5 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$1.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Scopia Capital Management
New York
|
-$10.2M |
| 2 |
DM
Deerfield Management
New York
|
-$9.07M |
| 3 |
Goldman Sachs
New York
|
-$5.78M |
| 4 |
PA
Perceptive Advisors
New York
|
-$2.81M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$1.87M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
51
Perceptive Advisors
New York
| – | -$2.81M | -226,322 | Closed |
|
52
Alyeska Investment Group
Chicago,
Illinois
| – | -$1.25M | -100,404 | Closed |
|
|
IHM
53
Iguana Healthcare Management
New York
| – | -$622K | -50,000 | Closed |
|
|
PHK
54
Point72 Hong Kong
Hong Kong
| – | -$113K | -9,062 | Closed |
|
55
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
| – | -$59K | -5,400 | Closed |
|
|
CSS
56
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$38K | -3,081 | Closed |
|
|
NFG
57
Next Financial Group
Houston,
Texas
| – | -$24K | -1,900 | Closed |
|
MYOV Hedge Fund Activity: Q1 2017 in Review
48 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q1 2017, worth a combined $577M — down 7.1% from $621M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new MYOV positions and 9 closed out — a net gain of 1 holder — while 17 added to existing stakes and 11 trimmed.
The largest buyer was BlackRock, adding an estimated $14.6M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $10.2M sold.
- 48 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q1 2017, down from 52 in Q4 2016.
- Funds reported $577M of Myovant Sciences Ltd. stock for Q1 2017, down 7.1% quarter-over-quarter.
- 10 funds opened new Myovant Sciences Ltd. positions in Q1 2017 and 9 closed out, a net change of +1 holder.
- The largest Myovant Sciences Ltd. buyer in Q1 2017 was BlackRock, an estimated $14.6M added.
- The largest Myovant Sciences Ltd. seller in Q1 2017 was Scopia Capital Management, an estimated $10.2M sold.
Based on aggregated 13F filings for Q1 2017.